BlackRock (GOSS) discloses 4.89M-share, 1% beneficial stake in Gossamer Bio

Rhea-AI Filing Summary

BlackRock, Inc. filed an amended ownership report on Gossamer Bio, Inc. common stock. BlackRock reports beneficial ownership of 4,890,593 shares, representing 1.0% of the class as of June 30, 2026. These shares are held with sole voting power and sole dispositive power, with no shared voting or dispositive power reported.

The filing notes that the position reflects securities beneficially owned, or deemed beneficially owned, by certain business units of BlackRock and its subsidiaries and affiliates. Various underlying clients have rights to dividends or sale proceeds, but no single person has more than five percent of Gossamer Bio’s outstanding common shares.

Key Figures

Beneficially owned shares: 4,890,593 shares Percent of class: 1.0% Sole voting power: 4,890,593 shares +3 more

6 metrics

Beneficially owned shares 4,890,593 shares Common stock of Gossamer Bio, Inc. beneficially owned by BlackRock, Inc.

Percent of class 1.0% Portion of Gossamer Bio common stock class beneficially owned by BlackRock, Inc.

Sole voting power 4,890,593 shares Shares over which BlackRock, Inc. has sole power to vote or direct the vote

Sole dispositive power 4,890,593 shares Shares over which BlackRock, Inc. has sole power to dispose or direct disposition

Ownership threshold 5 percent BlackRock reports ownership of five percent or less of the class

Ownership date 06/30/2026 Date as of which the beneficial ownership information is stated

Key Terms

beneficially owned, sole voting power, sole dispositive power, parent holding company, +1 more

5 terms

beneficially owned financial

"reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole Voting Power 4,890,593.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 4,890,593.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

parent holding company financial

"Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company"

Power of Attorney regulatory

"Exhibit 24: Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/29/2026 - 03:21 PM Accepted by SEC EDGAR 07/29/2026 - 03:19 PM Learn about SEC filing dates

FAQ

How many Gossamer Bio (GOSS) shares does BlackRock report owning?

BlackRock reports beneficial ownership of 4,890,593 Gossamer Bio common shares. This entire amount is reported with sole voting and sole dispositive power, meaning BlackRock alone controls how these shares are voted and disposed of.

What percentage of Gossamer Bio (GOSS) does BlackRock’s stake represent?

BlackRock’s reported stake represents 1.0% of Gossamer Bio’s outstanding common stock. The filing is an amended Schedule 13G/A and confirms that BlackRock’s beneficial ownership is at or below the five percent reporting threshold.

Does BlackRock share voting power over its Gossamer Bio (GOSS) shares?

No. BlackRock reports sole voting power over 4,890,593 shares and no shared voting power. It also reports sole dispositive power over the same number of shares, indicating exclusive control over how those shares may be sold or transferred.

Who ultimately benefits from BlackRock’s Gossamer Bio (GOSS) holdings?

The filing states that various persons have rights to receive dividends or sale proceeds from these shares. However, no single person’s interest relates to more than five percent of Gossamer Bio’s total outstanding common shares.

Which BlackRock entities are covered in this Gossamer Bio (GOSS) ownership report?

The reported holdings reflect securities beneficially owned, or deemed beneficially owned, by certain business units of BlackRock, Inc. and its subsidiaries and affiliates. Other BlackRock business units may be disaggregated and are not included in this position.

What is the effective date of BlackRock’s Gossamer Bio (GOSS) ownership information?

The ownership information is stated as of June 30, 2026. The Schedule 13G/A amendment was signed on July 29, 2026, by Spencer Fleming, Managing Director of BlackRock, Inc.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

GOSSAMER BIO, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

38341P102

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 38341P102

1

Names of Reporting Persons

BlackRock, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,890,593.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,890,593.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,890,593.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.0 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GOSSAMER BIO, INC.
(b)	Address of issuer's principal executive offices: 3115 MERRYFIELD ROW, SUITE 120 SAN DIEGO CA 92121
Item 2.
(a)	Name of person filing: BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)	Address or principal business office or, if none, residence: BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)	Citizenship: See Item 4 of Cover Page
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 38341P102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4890593
(b)	Percent of class: 1.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4890593
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4890593
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of GOSSAMER BIO, INC.. No one person's interest in the common stock of GOSSAMER BIO, INC. is more than five percent of the total outstanding common shares.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BlackRock, Inc.

Signature:	Spencer Fleming
Name/Title:	Managing Director
Date:	07/29/2026

Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7